Rotonya Carr, MD, FACP, Division Head of Gastroenterology at University of Washington joined us for a conversation about the changes in terminology for fatty liver disease and what this means for patients. This video was recorded December 2023.
Learn more about NAFLD/NASH* clinical trial opportunities here: [ Ссылка ]
If you've liked what you've seen on this video, then please consider clicking the red "Subscribe" button to be notified when new videos from the American Liver Foundation are posted. Click "Like" and "Share" this with your friends. Leave a comment below and we'll respond as soon as possible. Thank you.
*NAFLD has been newly renamed metabolic dysfunction-associated steatotic liver disease or MASLD. NASH has been newly renamed metabolic dysfunction associated steatohepatitis or MASH. Learn more about both here: [ Ссылка ]
